← Back to Search

Dietary Supplement

Iron Supplementation for Blood Donation (UH3BLIS Trial)

N/A
Recruiting
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
individuals between 18 - 60 years who weigh at least 50kg
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

UH3BLIS Trial Summary

This trial will compare the effectiveness of low-dose iron supplementation among blood donors who were deferred due to low hemoglobin levels but meet all other requirements, to a group of donors who were deferred and only

Who is the study for?
This trial is for individuals aged 18-60, weighing at least 50kg, who meet the physical criteria for blood donation but were deferred due to low haemoglobin. They must understand English, Twi, Ewe, or Ga and be willing to stay in the study for its full length.Check my eligibility
What is being tested?
The trial compares a group taking low-dose iron supplements daily with those receiving only nutrition counseling after being deferred from blood donation due to low haemoglobin. Success is measured by their ability to donate blood within a year.See study design
What are the potential side effects?
Potential side effects of the iron supplementation may include issues with the lower gastrointestinal system. Safety and compliance will be monitored through monthly phone calls.

UH3BLIS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old and weigh at least 50kg.

UH3BLIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants with a successful blood donation
Secondary outcome measures
Proportion of participants who attempt blood donation

UH3BLIS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Iron SupplementationExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,849 Previous Clinical Trials
47,816,829 Total Patients Enrolled
1 Trials studying Blood Donation
35,000 Patients Enrolled for Blood Donation
Syracuse UniversityOTHER
48 Previous Clinical Trials
117,082 Total Patients Enrolled
University of MinnesotaLead Sponsor
1,391 Previous Clinical Trials
1,552,616 Total Patients Enrolled
1 Trials studying Blood Donation
35,000 Patients Enrolled for Blood Donation
~352 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top